Delivery Order SPE2DB25D2207-SPE2DB25FQQPY
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen 3 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,755.63 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 18, 2024, with a completion date of July 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,612.40 firm fixed price delivery order is for the period through August 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award is for the delivery of the pharmaceutical product Ozempic (0.25-0.5 mg/dose, 3 mL pen) to the Defense Logistics Agency (DLA). The $4,264.30 firm-fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 27, 2024. The contract has an ultimate completion date of June 28, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,433.87 firm fixed price delivery order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has a completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,051.59, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 ml). The contract, valued at $3,006.54, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price arrangement with a period of performance ending on March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $2,902.70 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of...
This federal contract award is a delivery order (SPE2DB20D2200|SPE2DB24FW81Z) valued at $8,019.24 for the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL) placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award has a firm fixed price and a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,991.18 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, with an ultimate completion date of October 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,959.56, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract is a firm-fixed-price arrangement with a completion date of June 28, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...